{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:36:38Z","timestamp":1761676598826,"version":"3.41.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005969","name":"University of Bologna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007746","name":"Rizzoli Orthopaedic Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007746","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ejpb.2018.02.018","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T07:46:28Z","timestamp":1518680788000},"page":"120-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["A new multifunctionalized material against multi-drug resistant bacteria and abnormal osteoclast activity"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3754-0273","authenticated-orcid":false,"given":"Elisa","family":"Boanini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Torricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8101-9835","authenticated-orcid":false,"given":"Francesca","family":"Bonvicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7155-8744","authenticated-orcid":false,"given":"Maria Cristina","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Fini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna Angela","family":"Gentilomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-8627","authenticated-orcid":false,"given":"Adriana","family":"Bigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.02.018_b0005","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1016\/j.actbio.2012.06.022","article-title":"Controlling the biological function of calcium phosphate bone substitutes with drugs","volume":"8","author":"Verron","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2018.02.018_b0010","series-title":"Foundamentals and Applications","first-page":"235","article-title":"Ion substitution in biological and synthetic apatites \u2013 in biomineralization and biomaterials","author":"Bigi","year":"2015"},{"key":"10.1016\/j.ejpb.2018.02.018_b0015","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1021\/acs.biomac.5b00773","article-title":"Metal-based antibacterial substrates for biomedical applications","volume":"16","author":"Paladini","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2018.02.018_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcis.2015.01.088","article-title":"Strontium and zoledronate hydroxyapatites graded composite coatings for bone prostheses","volume":"448","author":"Boanini","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2018.02.018_b0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biomaterials.2011.09.092","article-title":"The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro","volume":"33","author":"Boanini","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.02.018_b0030","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1002\/adma.201301129","article-title":"Crystalline calcium alendronate obtained by octacalcium phosphate digestion: a new chance for local treatment of bone loss diseases?","volume":"25","author":"Boanini","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2018.02.018_b0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the First 40 Years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.ejpb.2018.02.018_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2007.07.007","article-title":"Bisphosphonates in cancer therapy","volume":"257","author":"Stresing","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejpb.2018.02.018_b0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.ejpb.2018.02.018_b0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00223-004-0024-1","article-title":"From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates","volume":"75","author":"Rogers","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ejpb.2018.02.018_b0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bone.2009.05.008","article-title":"Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy","volume":"45","author":"Favia","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.ejpb.2018.02.018_b0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00198-010-1453-5","article-title":"Subtrochanteric fractures after long-term treatment with bisphosphonates: a European society on clinical and economic aspects of osteoporosis and osteoarthritis, and international osteoporosis foundation working group report","volume":"22","author":"Rizzoli","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ejpb.2018.02.018_b0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.drudis.2013.08.010","article-title":"Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?","volume":"19","author":"Verron","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2018.02.018_b0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.actbio.2014.09.006","article-title":"Local drug delivery for enhancing fracture healing in osteoporotic bone","volume":"11","author":"Kyll\u00f6nen","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2018.02.018_b0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jbm.a.31989","article-title":"Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro","volume":"89A","author":"Faucheux","year":"2009","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2018.02.018_b0080","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1016\/j.biomaterials.2014.03.053","article-title":"Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses","volume":"35","author":"Boanini","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.02.018_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1745-7599.2011.00600.x","article-title":"Evidence-based review of silver dressing use on chronic wounds","volume":"23","author":"Toy","year":"2011","journal-title":"J. Am. Acad. Nurse Pract."},{"key":"10.1016\/j.ejpb.2018.02.018_b0090","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1039\/c0cc05271j","article-title":"Health impact and safety of engineered nanomaterials","volume":"47","author":"Teow","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejpb.2018.02.018_b0095","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1365-2672.2012.05253.x","article-title":"Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria","volume":"112","author":"Rai","year":"2012","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.ejpb.2018.02.018_b0100","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.actbio.2011.11.017","article-title":"Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review","volume":"8","author":"Bose","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2018.02.018_b0105","doi-asserted-by":"crossref","first-page":"225103","DOI":"10.1088\/0957-4484\/18\/22\/225103","article-title":"Characterization of enhanced antibacterial effects of novel silver nanoparticles","volume":"18","author":"Shrivastava","year":"2007","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ejpb.2018.02.018_b0110","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1021\/la2042058","article-title":"Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types","volume":"28","author":"Suresh","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2018.02.018_b0115","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3","article-title":"A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus","volume":"52","author":"Feng","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2018.02.018_b0120","article-title":"Silver nanoparticles in alveolar bone surgery devices","volume":"975842","author":"Sivolella","year":"2012","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejpb.2018.02.018_b0125","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1016\/j.biomaterials.2011.08.085","article-title":"The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles","volume":"32","author":"Park","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.02.018_b0130","doi-asserted-by":"crossref","first-page":"13849","DOI":"10.3390\/ijms150813849","article-title":"Antibacterial surface treatment for orthopaedic implants","volume":"15","author":"Gallo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2018.02.018_b0135","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1302\/0301-620X.97B5.33336","article-title":"Silver nanoparticles and their orthopaedic applications","volume":"97-B","author":"Brennan","year":"2015","journal-title":"Bone Joint J."},{"key":"10.1016\/j.ejpb.2018.02.018_b0140","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/j.actbio.2012.04.004","article-title":"Antibacterial and biological characteristics of silver containing and strontium doped plasma sprayed hydroxyapatite coatings","volume":"8","author":"Fielding","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2018.02.018_b0145","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jbm.a.31197","article-title":"Antibacterial and osteogenic properties of silver-containing hydroxyapatite coatings produced using a sol gel process","volume":"82A","author":"Chen","year":"2007","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2018.02.018_b0150","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1021\/am504716g","article-title":"Proposed mechanism of antibacterial action of chemically modified apatite for reduced bone infection","volume":"6","author":"Lim","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2018.02.018_b0155","first-page":"25","article-title":"Comparative study on preparation and characterization of bioactive coatings for biomedical applications \u2013 a review on recent patents and literature","volume":"48","author":"Furk\u00f3","year":"2017","journal-title":"Rev. Adv. Mater. Sci."},{"key":"10.1016\/j.ejpb.2018.02.018_b0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jbm.a.30895","article-title":"One step synthesis of silver nanorods by autoreduction of aqueous silver ions with hydroxyapatite: an inorganic\u2013inorganic hybrid nanocomposite","volume":"80A","author":"Arumugam","year":"2007","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2018.02.018_b0165","first-page":"6","article-title":"Synthesis and antimicrobial activity of a silver-hydroxyapatite nanocomposite","author":"Diaz","year":"2009","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejpb.2018.02.018_b0170","doi-asserted-by":"crossref","first-page":"33972","DOI":"10.1021\/acsami.6b09457","article-title":"Dopamine modified organic\u2212inorganic hybrid coating for antimicrobial and osteogenesis","volume":"8","author":"Li","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2018.02.018_b0175","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1021\/acsami.6b15979","article-title":"Fabrication of antibacterial and antiwear hydroxyapatite coatings via in situ chitosan-mediated pulse electrochemical deposition","volume":"9","author":"Yan","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2018.02.018_b0180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1039\/C3RA45846F","article-title":"Cationic-anionic polyelectrolyte interaction as a tool to graft silver nanoparticles on hydroxyapatite crystals and prevent cytotoxicity","volume":"4","author":"Boanini","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2018.02.018_b0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11095-004-1874-y","article-title":"Cross-linked small polyethylenimines: while still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo","volume":"22","author":"Thomas","year":"2005","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ejpb.2018.02.018_b0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03009740310000102","article-title":"Osteoclast formation from circulating precursors in osteoporosis","volume":"32","author":"Jevon","year":"2003","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejpb.2018.02.018_b0195","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1007\/s11357-015-9819-4","article-title":"In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytes","volume":"37","author":"Salamanna","year":"2015","journal-title":"Age"},{"key":"10.1016\/j.ejpb.2018.02.018_b0200","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.3892\/etm.2017.5260","article-title":"Identification of microRNAs in human circulating monocytes of postmenopausal osteoporotic Mexican-Mestizo women: a pilot study","volume":"14","author":"Jim\u00e9nez-Ortega","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejpb.2018.02.018_b0205","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0731-7085(02)00021-3","article-title":"Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions","volume":"28","author":"Kuljanin","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2018.02.018_b0210","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1574-6976.2011.00298.x","article-title":"Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology","volume":"36","author":"Croxatto","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejpb.2018.02.018_b0215","unstructured":"EUCAST: The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, 2016. <http:\/\/www.eucast.org>."},{"key":"10.1016\/j.ejpb.2018.02.018_b0220","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-fifth Informational Supplement. CLSI document M100-S25, 2015."},{"key":"10.1016\/j.ejpb.2018.02.018_b0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jac\/dks372","article-title":"The silver cation (Ag+): antistaphylococcal activity, mode of action and resistance studies","volume":"68","author":"Randall","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2018.02.018_b0230","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2217\/fmb.11.117","article-title":"Scenery of Staphylococcus implant infections in orthopedics","volume":"6","author":"Montanaro","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ejpb.2018.02.018_b0235","first-page":"3357","article-title":"Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus \u03b2-lactams","volume":"70","author":"Ribera","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2018.02.018_b0240","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0168-6445(03)00047-0","article-title":"Bacterial silver resistance: molecular biology and uses and misuses of silver compounds","volume":"27","author":"Silver","year":"2003","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejpb.2018.02.018_b0245","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1128\/AAC.00026-15","article-title":"Unprecedented silver resistance in clinically isolated Enterobacteriaceae: major implications for burn and wound management","volume":"59","author":"Finley","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2018.02.018_b0250","doi-asserted-by":"crossref","first-page":"e0164137","DOI":"10.1371\/journal.pone.0164137","article-title":"Molecular mechanism of silver nanoparticles-induced human osteoblast cell death: protective effect of inducible nitric oxide synthase inhibitor","volume":"11","author":"Zielinska","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.02.018_b0255","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jbspin.2010.11.015","article-title":"Bone disease in cystic fibrosis: what's new?","volume":"78","author":"Javier","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ejpb.2018.02.018_b0260","first-page":"2","article-title":"Bone health and disease in cystic fibrosis","volume":"20S","author":"Marquette","year":"2016","journal-title":"Paediatr. Respir. Rev."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117311864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117311864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:15:07Z","timestamp":1751404507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117311864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":52,"alternative-id":["S0939641117311864"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.02.018","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new multifunctionalized material against multi-drug resistant bacteria and abnormal osteoclast activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}